Markets.com Logo

MRK

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    100.8782$
  • Previous Close
    100.2879$
  • 52 Week Change
    41.13$
  • Day Range
    0.59$
  • 52 Week High/Low
    64.2711$ - 105.4$
  • Dividend Per Share
    0.0319
  • Market cap
    249 217 M$
  • EPS
    1.62
  • Beta
    0.264
  • Volume
    --

About

MRK.VI represents the stock of Merck & Co., Inc. traded on the Vienna Stock Exchange. Merck & Co., Inc. is a global healthcare company focused on discovering, developing, manufacturing, and marketing a wide range of innovative medicines, vaccines, and animal health products. The company's offerings primarily target diseases such as cancer, HIV, diabetes, and cardiovascular ailments, among others. Investing in MRK.VI provides exposure to the financial performance of Merck & Co. and the broader pharmaceutical industry.

Howard Marks on Market Cycles, Value Investing Logic, and Current Economic Shifts

Sophia Claire|--
EUR/USD Forecast: EUR/USD Eyes Key Resistance, Will the Dollar Bounce or Continue to Slide?

EUR/USD Forecast: EUR/USD Eyes Key Resistance, Will the Dollar Bounce or Continue to Slide?

Ghko B|--

Market Resilience Amidst Geopolitical Tensions: HSBC's Optimistic Strategic Outlook

Sophia Claire|--
Apple stock analysis: Could Apple stock soar under its new CEO John Ternus?

Apple stock analysis: Could Apple stock soar under its new CEO John Ternus?

Ghko B|--
BTC/EUR Outlook April 2026: Will Bitcoin Ignite a Massive Bull Run for European Investors?

BTC/EUR Outlook April 2026: Will Bitcoin Ignite a Massive Bull Run for European Investors?

Ghko B|--

Kuwait Declares Force Majeure on Oil Shipments Amidst Strait of Hormuz Blockade: Impacts and Recovery Outlook

Emma Rose|--

Iran's Uranium Transfer: Navigating Complex Logistics and Diplomatic Hurdles

Emma Rose|--

Factors

Company Performance: Merck's financial health, revenue growth, profitability, and pipeline of new drugs significantly influence investor confidence.

Industry Trends: Developments in the pharmaceutical sector, including regulatory changes, competitor activities, and technological advancements, impact the overall outlook.

Economic Conditions: Macroeconomic factors such as interest rates, inflation, and global economic growth can affect investment decisions and overall market sentiment.

Regulatory Environment: Drug approvals, patent expirations, and government policies on healthcare pricing directly impact Merck's revenue streams and profitability.

Market Sentiment: Investor perception, news coverage, and general market optimism or pessimism can drive stock price fluctuations.

Specific News: Announcements regarding clinical trial results, mergers, acquisitions, or collaborations can trigger immediate price reactions.

Global Events: Geopolitical events, pandemics, and other global crises can introduce uncertainty and volatility in the market, affecting stock prices.

Currency Fluctuations: Changes in the exchange rate between the Euro and other major currencies can affect the value of Merck's international sales and profits.

Investor Expectations: Market expectations about Merck's future performance, based on analysts' reports and earnings forecasts, influence buying and selling decisions.

People Also Watch

Latest news

US Extends Ceasefire with Iran Amidst Internal Divisions Hindering Talks

Ava Grace|--

Ukraine Warns of Escalating Nuclear Risks as Russian Drones and Missiles Operate Near Reactors

Sophia Claire|--

Tesla Earnings: Future Ventures Take Center Stage Amidst Investor Scrutiny

Noah Lee|--

Latest Education Articles

Why Is Gold Valuable? History, Scarcity, and What Still Drives Demand Today

Why Is Gold Valuable? History, Scarcity, and What Still Drives Demand Today

Julian Parker|--
Leveraged ETFs Explained: How They Work, What the Risks Are, and What Traders Should Know

Leveraged ETFs Explained: How They Work, What the Risks Are, and What Traders Should Know

Julian Parker|--
Trading vs Investing: Which Is More Profitable in 2026 ?

Trading vs Investing: Which Is More Profitable in 2026 ?

Julian Parker|--
Recommended Topics